Kumar Rajamani

Dr. Kumar Rajamani

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2022 in Signal, Image and Video Processing
Verified
Journal Article
Closed access
PDF file
KRKumar Rajamani
Kumar Rajamani
PRPriya Rani
Priya Rani
HSHanna Siebert
Hanna Siebert
RERajkumar ElagiriRamalingam
Rajkumar ElagiriRamalingam
MHMattias P. Heinrich
Mattias P. Heinrich

20 May 2021 in Journal of Biomedical Informatics
Verified
Journal Article
Closed access
KRKumar Rajamani
Kumar Rajamani
HSHanna Siebert
Hanna Siebert
MHMattias P. Heinrich
Mattias P. Heinrich

1 April 2013 in Stroke
Verified
Journal Article
Closed access
KRKumar Rajamani
Kumar Rajamani
KKKevin F. Kennedy
Kevin F. Kennedy
NRNicholas J. Ruggiero
Nicholas J. Ruggiero
KRKenneth Rosenfield
Kenneth Rosenfield
JSJohn Spertus
John Spertus
GGGiuseppe Giordano
Giuseppe Giordano
Background and Purpose— Benchmark trials of carotid endarterectomy often did not include elderly patients, and the results may not be easily extrapolated to the general population. Using the Carotid Artery Revascularization and Endarterectomy registry, we sought to determine real-world outcomes of carotid endarterectomy in the elderly. Methods— This was a retrospective cohort study of patients aged >70 years. We compared outcomes stratified by age among symptomatic and asymptomatic patients. Results— There were 4149 patients who underwent carotid endarterectomy; 1376 (33.1%) were symptomatic. Overall mortality rate was 0.5%. The primary outcome of in-hospital death, stroke, and myocardial infarction showed a significant trend and was highest in the age >85 years group (5.6%). Among symptomatic patients, mortality and the primary outcome were not statistically different between those aged >75 years and those aged 70 to 74 years. Among asymptomatic elderly patients, mortality rate was significantly higher in age group >75 years compared with <75 years (0.7% vs 0.0%); however, the combined outcome of stroke, death, and myocardial infarction was not statistically different. Conclusions— Elderly patients >85 years of age were at increased risk for death or perioperative complications of stroke, death, and myocardial infarction compared with those who were relatively younger. More elderly patients underwent carotid endarterectomy for asymptomatic carotid stenosis and had higher mortality than the younger counterparts, underlining need for caution in subjecting them to the procedure.

1 July 2009 in Stroke
Verified
Journal Article
Closed access
PDF file
KRKumar Rajamani
Kumar Rajamani
SCSeemant Chaturvedi
Seemant Chaturvedi
ZJZhezhen Jin
Zhezhen Jin
SHShunichi Homma
Shunichi Homma
RBRobin L. Brey
Robin L. Brey
SLSteven R. Levine
Steven R. Levine
Background and Purpose— We sought to estimate risk of recurrent stroke/TIA/death in the subgroup of the Patent Foramen Ovale in the Cryptogenic Stroke Study (PICSS) cohort with patent foramen ovale (PFO) and antiphospholipid antibodies (aPL) and to estimate risk of recurrent stroke/TIA/death in aPL-positive patients who have thickened left-side heart valves (VaT). PFO is associated with cryptogenic ischemic stroke. Also, the presence of aPL is associated with ischemic cerebrovascular disease. Methods— Combined data from 2 major substudies of the Warfarin Aspirin Recurrent Stroke Trial (WARSS) were evaluated. PICSS subjects were included if they were enrolled in the Antiphospholipid Antibodies and Stroke Study (APASS) and underwent a baseline aPL test (lupus anticoagulant, anticardiolipin antibodies, or both) within 1 month of the stroke. All patients in PICSS underwent transesophageal echocardiography for PFO as well as VaT, which was performed blinded to aPL status and treatment arm (325 mg/day aspirin or adjusted dose warfarin; target international normalized ratio, 1.4–2.8). The primary outcome event was the 2-year risk of recurrent stroke/TIA/death and was evaluated using Cox proportional hazards model. Because there was no treatment effect, warfarin and aspirin groups were combined to increase power. For the combined end point, power to detect HR of 2 was 47.8% for the PFO and aPL-positive group, and 75.3% for the valve thickening and aPL-positive group, assuming 2-sided type I error of 0.05. Results— Five hundred twenty-five subjects were tested for the combined presence of PFO and aPL and were available for evaluation. The primary outcome event rate was 23.9% (HR, 1.39; 95% CI, 0.75–2.59) in the PFO-positive/aPL-positive group, compared to 13.9% (HR, 0.83; 95% CI, 0.44–1.56) in the PFO-positive/aPL-negative group, and 19.9% (HR, 1.16; 95% CI, 0.68–1.90) in the PFO-negative/aPL-positive group. Five hundred forty-five subjects tested for combined presence of aPL and left-side cardiac VaT were available for evaluation. The primary event rate was 22.6% (HR, 1.65; 95% CI, 0.88–3.09) in the VaT-positive/aPL-positive group, compared to 19.4% (HR, 1.50; 95% CI, 0.82–2.75) in the VaT-positive/aPL-negative group, and 20.2% (HR, 1.63; 95% CI, 0.81–3.25) in the VaT-negative/aPL-positive group. Conclusions— The combined presence of aPL either with a PFO or with left-side cardiac VaT did not significantly increase risk of subsequent cerebrovascular events in this PICCS/APASS cohort of patients.

1 January 2013 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
KRKumar Rajamani
Kumar Rajamani
SMScott Millis
Scott Millis
SWSam Watson
Sam Watson
FMFlicia Mada
Flicia Mada
LSLeeza Salowich-Palm
Leeza Salowich-Palm
SCSeemant Chaturvedi
Seemant Chaturvedi

5 May 2004
Verified
Conference Paper
Closed access
PDF file
KRKumar Rajamani
Kumar Rajamani
JHJohannes Hug
Johannes Hug
LNLutz P. Nolte
Lutz P. Nolte
MSMartin Styner
Martin Styner
This paper addresses the problem of extrapolating extremely sparse three-dimensional set of digitized landmarks and bone surface points to obtain a complete surface representation. The extrapolation is done using a statistical principal component analysis (PCA) shape model similar to earlier approaches by Fleute et al. This extrapolation procedure called Bone-Morphing is highly useful for intra-operative visualization of bone structures in image-free surgeries. We developed a novel morphing scheme operating directly in the PCA shape space incorporating the full set of possible variations including additional information such as patient height, weight and age. Shape information coded by digitized points is iteratively removed from the PCA model. The extrapolated surface is computed as the most probable surface in the shape space given the data. Interactivity is enhanced, as additional bone surface points can be incorporated in real-time. The expected accuracy can be visualized at any stage of the procedure. In a feasibility study, we applied the proposed scheme to the proximal femur structure. 14 CT scans were segmented and a sequence of correspondence establishing methods was employed to compute the optimal PCA model. Three anatomical landmarks, the femoral notch and the upper and the lower trochanter are digitized to register the model to the patient anatomy. Our experiments show that the overall shape information can be captured fairly accurately by a small number of control points. The added advantage is that it is fast, highly interactive and needs only a small number of points to be digitized intra-operatively.